Front Oncol: The effect of chemotherapy on the prognosis of patients with stage I nasopharyngeal carcinoma

Radiotherapy and chemotherapy are recommended for stage II and locally advanced nasopharyngeal carcinoma

Radiotherapy and chemotherapy are recommended for stage II and locally advanced nasopharyngeal carcinoma

The study extracts relevant data of stage I nasopharyngeal carcinoma patients from 2010 to 2015 from the SEER database

The study extracts relevant data of stage I nasopharyngeal carcinoma patients from 2010 to 2015 from the SEER database

A total of 226 patients were enrolled

Clinical features

Before PSM, the 3-year OS (74.

Before PSM, the 3-year OS (74.

Comparison of prognosis before PSM

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.

Factors related to prognosis before PSM

Similarly, in the PSM matched cohort, 5-year OS (63.

Similarly, in the PSM matched cohort, 5-year OS (63.

Comparison of prognosis after PSM

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.

Multivariate regression analysis showed that chemoradiation was an independent risk prognosis for OS (HR = 2.
55, 95% CI: 1.
08-6.
00; P = 0.
032) and CSS (HR = 5.
87, 95% CI: 1.
14-30.
28; P = 0.
035) Factors
.

  Prognostic factors after PSM

  Prognostic factors after PSM

In summary, studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.

In summary, studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.
Studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.
Studies have shown that adding chemotherapy to radiotherapy does not improve the prognosis of patients with stage I nasopharyngeal carcinoma
.
Radiotherapy is still the recommended treatment for such patients
.

Original source:

Original source:

Ma JL, Huang ST, Jiang YM and Pan XB (2021) Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma.
Front.
Oncol.
11:735817.
doi: 10.
3389/fonc.
2021.
735817

.
.
Ma JL, Huang ST, Jiang YM and Pan XB (2021) Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma Front Oncol 11:.
735817 doi:.
10.
3389 / fonc.
2021.
735817

in this message